三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图表9不同疗法在生物制剂初治(左)和经治(右)患者中的药物留存率比较
图表9不同疗法在生物制剂初治(左)和经治(右)患者中的药物留存率比较
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:441KB
图片尺寸:1801*977
同报告图片
/
4
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
所属报告:
荃信生物~B(0509.HK)-港股公司深度研究报告:深耕自免领域单抗双抗全面布局-250912(33页).pdf
打包全文图表
相关数据
眼部疾病部分VEGF靶点生物制剂情况(截至20250730)
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
收藏
行业数据
2025-10-14
原图定位
查看详情
眼部疾病部分VEGF靶点生物制剂中标情况(截至20250730)
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
收藏
行业数据
2025-10-14
原图定位
查看详情
目前全球范围内上市十余款生物制剂/小分子靶向药用于AD治疗,Dupilumab销售额遥遥领先
<table border="1" cellspacing="0" cellpadding="5">
    <thead>
        <tr>
            <th>靶点</th>
            <th colspan="2">PDE4</th>
            <th colspan="4">JAK1</th>
            <th colspan="2">JAK1/2</th>
            <th colspan="2">IL - 4R</th>
            <th colspan="2">IL - 13</th>
            <th>IL - 31</th>
        </tr>
        <tr>
            <th>药物名称</th>
            <td>Crisaborole (EUCRISA)</td>
            <td>Difamilast</td>
            <td>Upadacitinib (RINVOQ)</td>
            <td>Abrocitinib (CIBINQO)</td>
            <td>Ivarmacitinib</td>
            <td>Delgocitinib</td>
            <td>Ruxolitinib phosphate (OPZELURA)</td>
            <td>Baricitinib (OLUMIANT)</td>
            <td>Dupilumab (DUPIXENT)</td>
            <td>CM310 (康悦达)</td>
            <td>Tralokinumab (ADBRY)</td>
            <td>Lebrikizumab</td>
            <td>Nemolizumab (Nemluvio)</td>
        </tr>
        <tr>
            <th>中文名称</th>
            <td>克立硼罗</td>
            <td>地法米司特</td>
            <td>乌帕替尼</td>
            <td>阿布昔替尼</td>
            <td>艾玛昔替尼</td>
            <td>迪高替尼</td>
            <td>磷酸芦可替尼</td>
            <td>巴瑞替尼</td>
            <td>度普利尤单抗</td>
            <td>司普奇拜单抗</td>
            <td>曲罗芦单抗</td>
            <td>来金珠单抗</td>
            <td>尼莫利珠单抗</td>
        </tr>
        <tr>
            <th>研发企业</th>
            <td>Anacor（辉瑞已收购）</td>
            <td>大家制药</td>
            <td>艾伯维</td>
            <td>辉瑞</td>
            <td>恒瑞医药</td>
            <td>日本烟草</td>
            <td>Incyte</td>
            <td>礼来</td>
            <td>再生元/赛诺菲</td>
            <td>康诺亚</td>
            <td>Leo</td>
            <td>礼来/罗氏</td>
            <td>中外制药株式会社</td>
        </tr>
        <tr>
            <th>获批AD时间</th>
            <td>FDA: 2016.12<br>EMA: 2020.03<br>CDE: 2020.07</td>
            <td>PMDA:2021.09</td>
            <td>FDA: 2022.01<br>EMA: 2019.12<br>CDE: 2022.02</td>
            <td>FDA: 2022.01<br>EMA: 2021.08<br>CDE: 2022.04</td>
            <td>CDE: 2025.04</td>
            <td>PMDA: 2020.01</td>
            <td>FDA: 2021.09</td>
            <td>EMA: 2017.02<br>FDA、CDE: 已上市但AD适应症未批</td>
            <td>FDA: 2017.03<br>EMA: 2017.09<br>CDE: 2020.06</td>
            <td>CDE:2024.09</td>
            <td>FDA: 2021.12<br>EMA: 2021.12</td>
            <td>FDA:2024.09<br>EMA: 2023.11</td>
            <td>FDA: 2024.12<br>EMA: 2025.02<br>PMDA:2022.03</td>
        </tr>
        <tr>
            <th>其他适应症</th>
            <td>无</td>
            <td>无</td>
            <td>巨细胞动脉炎、IBD、银屑病关节炎等</td>
            <td>无</td>
            <td>类风关、强直性脊柱炎、斑秃</td>
            <td>无</td>
            <td>白癜风</td>
            <td>斑秃、关节炎等</td>
            <td>COPD、哮喘、CRSwNP、结节性痒疹、荨麻疹等</td>
            <td>季节性过敏性鼻炎、CRSwNP</td>
            <td>无</td>
            <td>无</td>
            <td>结节性痒疹</td>
        </tr>
        <tr>
            <th>剂型</th>
            <td>软膏</td>
            <td>软膏</td>
            <td>口服</td>
            <td>口服</td>
            <td>口服</td>
            <td>口服</td>
            <td>软膏</td>
            <td>口服</td>
            <td>注射剂</td>
            <td>注射剂</td>
            <td>注射剂</td>
            <td>注射剂</td>
            <td>注射剂</td>
        </tr>
        <tr>
            <th>说明书用量</th>
            <td>软膏，外用</td>
            <td>软膏，外用</td>
            <td>15mg QD</td>
            <td>100mg QD</td>
            <td>4mg QD</td>
            <td>-</td>
            <td>乳膏</td>
            <td>4mg QD</td>
            <td>首次600mg，后300mg/Q2W</td>
            <td>首次600mg，后300mg/Q2W</td>
            <td>首次600mg，后300mg/Q2W</td>
            <td>0、2w各250mg，4 - 16w 250mg Q2W，16周后250mg Q4W</td>
            <td>60mg后30mg Q4W，16w后30mg Q8W</td>
        </tr>
        <tr>
            <th>化合物/序列专利到期时间</th>
            <td>中：2026.2<br>美：2029.12</td>
            <td>中：2026.11<br>美：2028.3</td>
            <td>中：2030.12<br>美：2033.8</td>
            <td>中：2034.2<br>美：2035.8</td>
            <td>2032.12</td>
            <td>中：2030.7<br>美：2031.9</td>
            <td>中：2026.12<br>美：2028.6</td>
            <td>中：2029/3/10<br>美：2031/5/31</td>
            <td>中：2029.10<br>美：2031.3</td>
            <td>中：2038.5<br>美：2039.5</td>
            <td>已失效</td>
            <td>中：已失效<br>美：2026.3</td>
            <td>2029.12</td>
        </tr>
        <tr>
            <th>国内价格（更新至2025年）</th>
            <td>160元/30g</td>
            <td>-</td>
            <td>74.5元/15mg</td>
            <td>67.6 元/100mg</td>
            <td>92.14元/4mg</td>
            <td>-</td>
            <td>-</td>
            <td>-</td>
            <td>38 元/2mg</td>
            <td>1508元/300mg</td>
            <td>1812元/300mg买二送一（实付1208元/支）</td>
            <td>$422.26/150mg</td>
            <td>-</td>
            <td>-</td>
        </tr>
        <tr>
            <th>首年花费（万元）</th>
            <td>-</td>
            <td>-</td>
            <td>2.72</td>
            <td>2.47</td>
            <td>3.36</td>
            <td>-</td>
            <td>-</td>
            <td>-</td>
            <td>2.77</td>
            <td>4.07</td>
            <td>3.26</td>
            <td>$2.28</td>
            <td>-</td>
            <td>-</td>
        </tr>
        <tr>
            <th>次年花费（万元）</th>
            <td>-</td>
            <td>-</td>
            <td>2.72</td>
            <td>2.47</td>
            <td>3.36</td>
            <td>-</td>
            <td>-</td>
            <td>-</td>
            <td>2.77</td>
            <td>7.23</td>
            <td>4.31</td>
            <td>$2.20</td>
            <td>-</td>
            <td>-</td>
        </tr>
        <tr>
            <th>2024年全球销售额</th>
            <td>NA</td>
            <td>$1.03亿</td>
            <td>$59.71亿</td>
            <td>$2.15亿</td>
            <td>NA</td>
            <td>NA</td>
            <td>$5.08亿</td>
            <td>$9.57亿</td>
            <td>$140.89亿</td>
            <td>约4000万元</td>
            <td>NA</td>
            <td>$4280万</td>
            <td>$2300万</td>
        </tr>
    </tbody>
</table>

资料来源：Insight，各产品药品说明书，国金证券研究所（价格统计截至2025年8月）
收藏
行业数据
2025-09-17
原图定位
查看详情
目前全球范围内上市十余款生物制剂/小分子靶向药用于AD治疗,Dupilumab销售额遥遥领先
<|begin_of_box|>| 靶点   | 药物名称（中英）                     | 研发企业               | 获批AD时间                                                                 | 其他适应症                         | 剂型   | 说明书用量                                 | 化合物/序列专利到期时间       | 国内价格（更新至2025年）       | 首年花费（万元） | 次年花费（万元） | 2024年全球销售额 |
|--------|--------------------------------------|------------------------|--------------------------------------------------------------------------|------------------------------------|--------|--------------------------------------------|------------------------------|-------------------------------|------------------|------------------|-------------------|
| PDE4   | Crisaborole (EUCRISA) 克立硼罗       | Anacor（辉瑞已收购）   | FDA: 2016.12<br>EMA: 2020.03<br>CDE: 2020.07                             | 无                                 | 软膏   | 软膏，外用                                 | 中：2026.2<br>美：2029.12     | 160元/30g                    | -                | -                | NA                |
| PDE4   | Difamilast 地法米司特                 | 大冢制药               | PMDA: 2021.09                                                             | 无                                 | 软膏   | 软膏，外用                                 | 中：2026.11<br>美：2028.3     | -                            | -                | -                | $1.03亿           |
| JAK1   | Upadacitinib (RINVOQ) 乌帕替尼       | 艾伯维                 | FDA: 2022.01<br>EMA: 2019.12<br>CDE: 2022.02                             | 巨细胞动脉炎、IBD、银屑病关节炎等   | 口服   | 15mg QD                                    | 中：2030.12<br>美：2033.8     | 74.5元/15mg                  | 2.72             | 2.72             | $59.71亿          |
| JAK1   | Abrocitinib (CIBINQO) 阿布昔替尼     | 辉瑞                   | FDA: 2022.01<br>EMA: 2021.08<br>CDE: 2022.04                             | 无                                 | 口服   | 100mg QD                                   | 中：2034.2<br>美：2035.8      | 67.6 元/100mg                 | 2.47             | 2.47             | $2.15亿           |
| JAK1   | Ivarmacitinib 艾玛昔替尼             | 恒瑞医药               | CDE: 2025.04                                                              | 类风关、强直性脊柱炎、斑秃           | 口服   | 4mg QD                                     | 2032.12                       | 92.14元/4mg                   | 3.36             | 3.36             | NA                |
| JAK1   | Delgocitinib 迪高替尼                | 日本烟草               | PMDA: 2020.01                                                             | 无                                 | 口服   | -                                          | 中：2030.7<br>美：2031.9      | -                            | -                | -                | NA                |
| JAK1/2 | Ruxolitinib phosphate (OPZELURA) 磷酸芦可替尼 | Incyte | FDA: 2021.09                                                             | 白癜风                             | 软膏   | 乳膏                                       | 中：2026.12<br>美：2028.6     | -                            | -                | -                | $5.08亿           |
| JAK1/2 | Baricitinib (OLUMIANT) 巴瑞替尼       | 礼来                   | EMA: 2017.02<br>FDA、CDE: 已上市但AD适应症未批                           | 斑秃、关节炎等                     | 口服   | 4mg QD                                     | 中：2029/3/10<br>美：2031/5/31 | 38 元/2mg                     | 2.77             | 2.77             | $9.57亿           |
| IL-4R  | Dupilumab (DUPIXENT) 度普利尤单抗    | 再生元/赛诺菲           | FDA: 2017.03<br>EMA: 2017.09<br>CDE: 2020.06                             | COPD、哮喘、CRSwNP、结节性痒疹、荨麻疹等 | 注射剂 | 首次600mg，后300mg/Q2W                      | 中：2029.10<br>美：2031.3     | 1508元/300mg                  | 4.07             | 7.23             | $140.89亿         |
| IL-4R  | CM310 (康悦达) 可善奇拜单抗          | 康诺亚                 | CDE: 2024.09                                                              | 季节性过敏性鼻炎、CRSwNP            | 注射剂 | 首次600mg，后300mg/Q2W                      | 中：2038.5<br>美：2039.5      | 1812元/300mg 买二送一（实付1208元/支） | 3.26             | 4.31             | 约4000万元        |
| IL-13  | Tralokinumab (ADBRY) 曲罗芦单抗      | Leo                    | FDA: 2021.12<br>EMA: 2021.12                                             | 无                                 | 注射剂 | 首次600mg，后0、2w各250mg，4-16w 250mg Q2W，16周后250mg Q4W | 已失效                        | $422.26/150mg                 | $2.28            | $2.20            | NA                |
| IL-13  | Lebrikizumab 来金珠单抗              | 礼来/罗氏               | FDA:2024.09<br>EMA: 2023.11                                              | 无                                 | 注射剂 | 首次600mg，后300mg/Q2W                      | 中：已失效<br>美：2026.3      | -                            | -                | -                | $4280万           |
| IL-31  | Nemolizumab (Nemluvio) 尼莫利珠单抗  | 中外制药株式会社        | FDA: 2024.12<br>EMA: 2025.02<br>PMDA:2022.03                            | 结节性痒疹                          | 注射剂 | 60mg后30mg Q4W，16周后30mg Q8W              | 2029.12                       | -                            | -                | -                | $2300万           |

来源：Insight，各产品药品说明书，国金证券研究所（价格统计截至2025年8月）<|end_of_box|>
收藏
行业数据
2025-09-17
原图定位
查看详情
2025~2034美国生物制剂及按专利到期年份的销售情况
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
收藏
行业数据
2025-08-14
原图定位
查看详情
我国现有治疗SLE的生物制剂概览
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
收藏
行业数据
2025-06-27
原图定位
查看详情
2018-30年中国银屑病药物市场中生物制剂占比预计逐渐增加
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
收藏
行业数据
2025-06-20
原图定位
查看详情
全球生物制剂CDMO市场有望持续增长
fCDlubTku70gIHwg6YeR6aKd77yI5Y2B5Lq/576O5YWD77yJIHwKfC0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIzICB8IH4kMjBibiAgICAgICAgfAp8IDIwMzBFIHwgPiQzMGJuICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrnk6blhYvlubTmiqXvvIzljY7ms7DnoJTnqbY=
收藏
行业数据
2025-06-03
原图定位
查看详情
2023年瓦克生物制剂市场销售额占比居全球前列
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOWItuWJguW4guWcuiB8IOWNoOavlCB8CnwgLS0tIHwgLS0tIHwKfCDpvpnmspkgfCAyMiUgfAp8IOWvjOWjq+iDtiB8IDE2JSB8Cnwg5YW25LuWIHwgMzglIHwKfCDnk6blhYsgfCA1JSB8Cnwg5YuD5p6X5qC85q635qC857+wIHwgMTAlIHwKfCBBR0MgfCAxMCUgfAoK6LWE5paZ5p2l5rqQ77ya55Om5YWL5bm05oql77yM5Y2O5rOw56CU56m2
收藏
行业数据
2025-06-03
原图定位
查看详情
表3呼吸疾病生物制剂及新靶点治疗药物不断获批上市
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
收藏
行业数据
2025-04-21
原图定位
查看详情
表3呼吸疾病生物制剂及新靶点治疗药物不断获批上市
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
收藏
行业数据
2025-04-01
原图定位
查看详情
IL-23和IL-17信号通路及相关生物制剂
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
收藏
行业数据
2025-03-25
原图定位
查看详情
图9.2020年美国UC生物制剂市场份额
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
收藏
竞争格局
2025-03-19
原图定位
查看详情
不同阶段CDMO项目管线订单价值(以生物制剂药品为例)
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
收藏
行业数据
2025-01-14
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
药物留存率是指对于给定药物的依从率和持续用药时间,受药物有效性、长期安全性以及患者和医生偏好等多重因素影响。银屑病生物制剂的药物留存率很好地反映了治疗的安全性、有效性、患者依从性和总体满意度,可作为银屑病的一种治疗目标。一项对 1,606名患者的分析显示,乌司奴单抗的药物留存率在生物制剂中具有优势,在生物制剂初治患者和经治患者中留存率水平都有较高水平。
行业数据
原图定位
当前图表所属:
荃信生物~B(0509.HK)-港股公司深度研究报告:深耕自免领域单抗双抗全面布局-250912(33页).pdf
图表9不同疗法在生物制剂初治(左)和经治(右)患者中的药物留存率比较
图表8银屑病代表性生物制剂疗法的给药方式
图表6银屑病中的免疫功能异常
图表5乌司奴单抗原研药喜达诺全球销售额(亿美元)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》